1.Exploring the Subjective Frame of Patient Satisfaction among Patients Admitted to the Comprehensive Nursing Care Service: Q Methodology Application
Ye-Na LEE ; Jeehyoung KIM ; Geon GO ; Purum KANG
Journal of Korean Academy of Nursing Administration 2021;27(5):323-333
Purpose:
This study examined the subjective frame of patient satisfaction in the comprehensive nursing care services and explored future directions by investigating subjective frame types.
Methods:
P-Samples were collected from 30 patients who underwent the comprehensive nursing care service. To enable a forced normal distribution, 31 Q-samples were classified on a 9-point scale considering the degree of agreement. The collected data were analyzed by principal component factor analysis and varimax rotation using the PQ method program.
Results:
The subjective frame of patient satisfaction with the comprehensive nursing care service was divided into four types. Considering the characteristics of each, the types were labeled as “the formation of relationships with the surroundings”, “autonomous decision-making”, “non-verbal empathy”, and “therapeutic support resources”. Each type can be classified into therapeutic relationship and therapeutic process categories.
Conclusion
This study revealed changes in expectations regarding new medical services and that the subjective frames that affect the formation of satisfaction are diverse. The study results are expected to be used as basic data to develop strategies for creating a therapeutic environment that improves patient satisfaction in the comprehensive nursing care service.
2.Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer.
Youngjoo LEE ; Ki Hyeong LEE ; Geon Kook LEE ; Soo Hyun LEE ; Kun Young LIM ; Jungnam JOO ; Yun Jung GO ; Jin Soo LEE ; Ji Youn HAN
Cancer Research and Treatment 2017;49(4):1001-1011
PURPOSE: This phase II study examined whether the addition of simvastatin to afatinib provides a clinical benefit compared with afatinib monotherapy in previously treated patients with nonadenocarcinomatous non-small cell lung cancer (NA-NSCLC). MATERIALS AND METHODS: Patients with advanced NA-NSCLC who progressed after one or two chemotherapy regimens were randomly assigned to a simvastatin (40 mg/day) plus afatinib (40 mg/day) (AS) arm or to an afatinib (A) arm. The primary endpoint was response rate (RR). RESULTS: Sixty-eight patients were enrolled (36 in the AS arm and 32 in the A arm). The RR was 5.7% (95% confidence interval [CI], 0.7 to 19.2) for AS and 9.4% (95% CI, 2.0 to 25.0) for A (p=0.440). In arms AS and A, the median progression-free survival (PFS) was 1.0 versus 3.6 months (p=0.240) and the overall survival was 10.0 months versus 7.0 months (p=0.930), respectively. Skin rash, stomatitis, and diarrhea were the most common adverse events in both arms. More grade 3 or 4 diarrhea was observed in arm A (18.8% vs. 5.6% in arm AS). In all patients, the median PFS for treatment including afatinib was not correlated with the status of epidermal growth factor receptor (EGFR) mutation (p=0.122), EGFR fluorescence in situ hybridization (p=0.944), or EGFR immunohistochemistry (p=0.976). However, skin rash severity was significantly related to the risk of progression for afatinib (hazard ratio for skin rash grade ≥ 2 vs. grade < 2, 0.44; 95% CI, 0.25 to 0.78; p=0.005). CONCLUSION: There were no significant differences in the efficacy between AS and A arms in patients with NA-NSCLC.
Arm
;
Carcinoma, Non-Small-Cell Lung*
;
Carcinoma, Squamous Cell
;
Diarrhea
;
Disease-Free Survival
;
Drug Therapy
;
Exanthema
;
Fluorescence
;
Humans
;
Hydroxymethylglutaryl-CoA Reductase Inhibitors
;
Immunohistochemistry
;
In Situ Hybridization
;
Receptor, Epidermal Growth Factor
;
Simvastatin*
;
Stomatitis
3.PCR Based Detection of Phellinus linteus using Specific Primers Generated from Universal Rice Primer (URP) Derived PCR Polymorphic Band.
Hee Wan KANG ; Dong Suk PARK ; Young Jin PARK ; Byoung Moo LEE ; Soo Muk CHO ; Ki Tae KIM ; Geon Sik SEO ; Seung Joo GO
Mycobiology 2002;30(4):202-207
This study was carried out to develop specific primers for PCR detection of Phellinus linteus. Diverse genomes of 15 Phellinus spp. including five Phellinus linteus isolates were fingerprinted by Primer Universal rice primer (URP)1F. The URP-PCR pattern differentiated P. linteus isolates from other phellinus spp. A polymorphic band (2.8 kb), which is unique for P. linteus isolates, was isolated and sequenced. Twenty four-oligonucleotide primer pairs were designed based on information of DNA sequence. The primer set (PLSPF2/PLSPR1) amplified single band (2.2 kb) of expected size with genomic DNA from seven Phellinus linteus, but not with that of other Phellinus species tested. The primers could be used identically in both DNA samples from mycelium and fruit bodies. This specific primers could offer a useful tool for detecting and identifying P. linteus rapidly.
Base Sequence
;
Dermatoglyphics
;
DNA
;
Fruit
;
Genome
;
Mycelium
;
Polymerase Chain Reaction*
4.Accuracy of GenediaTM H. pylori ELISA for the Diagnosis of Helicobacter pylori Infection in Korean Population.
In Sik CHUNG ; Sang Woo KIM ; Jae Sung GO ; Na Young KIM ; Jae Gyu KIM ; Jin Ho KIM ; Hak Yang KIM ; Jae Jun KIM ; Jae Geon SIM ; Im Hwan ROE ; Hyeong Sik AHN ; Byung Chul YOON ; Sang Woo LEE ; Yong Chan LEE ; Hwoon Yong JUNG ; Won Seon HONG ; Kyoo Wan CHOI
Korean Journal of Medicine 2001;61(1):17-23
BACKGROUND: GenediaTM H. pylori ELISA is a newly developed diagnostic method which detects serum anti-H. pylori IgG antibody. The aim of this study was to assess the accuracy of GenediaTM H. pylori ELISA for the diagnosis of H. pylori infection in Korean population. METHODS: GenediaTM H. pylori ELISA and GAP-IgG were performed in 353 adult sera and Pyloriset-IgG EIA in 184 subjects. In children, 43 serum samples were tested with GenediaTM H. pylori ELISA. H. pylori infection was determined by rapid urease test, histology, culture or 13C-urea breath test in adults. In children, the subject was considered to be H. pylori positive if 13C-urea breath test was positive. RESULTS: In adults, the sensitivity and specificity of GenediaTM H. pylori ELISA were 93.2% and 83.5% with positive and negative predictive values of 85.1% and 92.5%. Those for GAP-IgG and Pyloriset-IgG EIA were 67.2%, 82.4%, 79.3%, 71.4% and 89.1%, 88.4%, 71.9%, 96.1%, respectively. In children, sensitivity, specificity, positive and negative predictive values of GenediaTM H. pylori ELISA were 80%, 84.8%, 61.5%, and 93.3%. Sensitivity and negative predictive value of GenediaTM H. pylori ELISA were significantly higher than those of GAP-IgG (93.2% vs. 67.2%; plt;0.005 and 92.5% vs 71.4%; p<0.005, respectively). CONCLUSION: GenediaTM H. pylori ELISA is a relatively accurate method for the serodiagnosis of H. pylori infection in Korean subjects compared to GAP-IgG. These results may suggest the clinical use of GenediaTM H. pylori ELISA for epidemiological studies of H. pylori infection in Korea.
Adult
;
Breath Tests
;
Child
;
Diagnosis*
;
Enzyme-Linked Immunosorbent Assay*
;
Helicobacter pylori*
;
Helicobacter*
;
Humans
;
Immunoglobulin G
;
Korea
;
Sensitivity and Specificity
;
Serologic Tests
;
Urease